Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$16.01 USD
+0.31 (1.97%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $16.00 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.56 | 0.00% |
Earnings Summary
For their last quarter, Day One Biopharmaceuticals (DAWN) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.67 per share. This reflects a negative earnings surprise of 7.46%. Look out for DAWN's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 8.2%.
Earnings History
Price & Consensus
Zacks News for DAWN
Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More
DAWN: What are Zacks experts saying now?
Zacks Private Portfolio Services